AI for regulatory DNA: from prediction to validation

AlphaGenome Atlas: Understanding the human genome

Google DeepMind · 2026-09-08 · Source

The developer introduces the related AlphaGenome Atlas research resource. It complements the molecular prediction discussion; it is not a clinical demonstration.

Why examine regulatory regions?

The 2020 ENCODE study combined DNA accessibility and chromatin measurements to catalogue candidate regulatory regions in humans and mice.

What question does AlphaGenome address?

The 2026 AlphaGenome study predicts molecular outputs, including gene expression, RNA splicing and chromatin properties, from one million DNA bases.

Editorial reading: what should accompany a score?

We suggest reading a model output in three separate fields: the prediction, the experiment testing it and the limits of interpretation. Beside “an expression change is expected,” for example, record the cellular context and comparison used. Then ask whether an independent measurement supports that expectation. This helps prevent a numerical output from silently becoming a definitive diagnostic statement.

How could a research evaluation be organized?

Our editorial recommendation is to define the target task and failure criteria before the evaluation begins. Set aside examples absent from training and examine results separately for the selected tissues and variant groups. Keep the model version, data source and reviewer corrections in the same record. Show discordant results alongside successful examples. This is a study-design suggestion, not an established clinical acceptance standard.

Where is the boundary with clinical use?

The developer limits AlphaGenome predictions to research and states that they were not designed or validated for direct clinical purposes. This statement is not regulatory authorization.

What decision follows from this article?

Our interpretation is to assess tool selection alongside intended use and independent evidence. Research publications, software access and marketing authorization should have separate records. The studies discussed here are not presented as evidence of RAI product effectiveness; the article provides no personal genetic interpretation or treatment advice.